Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections

被引:45
作者
Hu, YW
Balaskas, E
Furione, M
Yen, PH
Kessler, G
Scalia, V
Chui, L
Sher, G
机构
[1] Canadian Blood Serv, Ottawa, ON K1G 4J5, Canada
[2] IRCCS Policlin, Serv Virol, I-27100 Pavia, Italy
[3] Microbiol & Publ Hlth, Edmonton, AB T6G 2J2, Canada
关键词
D O I
10.1128/JCM.38.8.2807-2813.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To date the true prevalence of hepatitis C virus (HCV) mixed-genotype infections has not been established mainly because currently available methods are not suitable for the detection of mixed genotypes in a viral population. A novel semiautomated genotyping method, primer-specific and mispair extension analysis (S-PSMEA), which is more reliable than other genotyping assays was developed for detection of HCV mixed-genotype infections. A genotype present at levels as low as 0.8% in a defined mix of HCV genotypes was detected, showing a 20-fold increase in sensitivity over that of direct DNA sequencing. A total of 434 HCV isolates were genotyped and analyzed for a comparative study of the accuracy between S-PSMEA and four current genotyping methods. The results showed that viruses in approximately 40% of the samples from this group determined to be infected with mixed genotypes by S-PSMEA were undetected by direct DNA sequencing due to its low sensitivity. Type-specific PCR, line probe assay, and restriction fragment length polymorphism analysis performed poorly, being able to identify only 38.5, 16.1, and 15.4% of mixed-genotype infections, respectively, that were detected by direct DNA sequencing. The prevalence of mixed-genotype infections detected by S-PSMEA was 7.9% (12 of 152 donors) among HCV-infected blood donors, 14.3% (15 of 105) among patients with chronic hepatitis C, and 17.1% (6 of 36) among thalassemia patients who had received multiple transfusions. The data lead us to conclude that HCV mixed-genotype infections are more common than previously estimated and that S-PSMEA may be the method of choice when detection of genotypes present at low levels in mixed-genotype infections is required due to its higher level of sensitivity.
引用
收藏
页码:2807 / 2813
页数:7
相关论文
共 27 条
[1]   Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[2]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[3]   GENOTYPING OF CANADIAN HEPATITIS-C VIRUS ISOLATES BY PCR [J].
ANDONOV, A ;
CHAUDHARY, RK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (08) :2031-2034
[4]   Identification of numerous hepatitis C virus genotypes in Montreal, Canada [J].
Bernier, L ;
Willems, B ;
Delage, G ;
Murphy, DG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (11) :2815-2818
[5]   GENETIC-HETEROGENEITY OF HEPATITIS-C VIRUS - QUASI-SPECIES AND GENOTYPES [J].
BUKH, J ;
MILLER, RH ;
PURCELL, RH .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :41-63
[6]   Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia [J].
Eyster, ME ;
Sherman, KE ;
Goedert, JJ ;
Katsoulidou, A ;
Hatzakis, A .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1062-1069
[7]   Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients [J].
Forns, X ;
Maluenda, MD ;
LopezLabrador, X ;
Ampurdanes, S ;
Olmedo, E ;
Costa, J ;
Simmonds, P ;
SanchezTapias, JM ;
DeAnta, MTJ ;
Rodes, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) :2516-2521
[8]   HCV genotyping by three methods: analysis of discordant results based on sequencing [J].
Furione, M ;
Simoncini, L ;
Gatti, M ;
Baldanti, F ;
Revello, MG ;
Gerna, G .
JOURNAL OF CLINICAL VIROLOGY, 1999, 13 (03) :121-130
[9]   Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses [J].
Garfein, RS ;
Vlahov, D ;
Galai, N ;
Doherty, MC ;
Nelson, KE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :655-661
[10]   Response to interferon in chronic hepatitis C due to mixed genotype infection [J].
Horiike, N ;
Masumoto, T ;
Michitaka, K ;
Kurose, K ;
Akbar, SMF ;
Onji, M .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (04) :353-357